GAIL JOHNSON: Open Payments
NPI 1902044308 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,552 in 96 payments from 10 companies in 2025. Trend: 2023 $1,357 · 2024 $1,013 · 2025 $1,552
Food & beverage: $1,552
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 19 | $372 |
| Lundbeck LLC | 14 | $288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $267 |
| ABBVIE INC. | 28 | $176 |
| E.R. Squibb & Sons, L.L.C. | 12 | $166 |
| Otsuka America Pharmaceutical, Inc. | 5 | $151 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: ARISTADA, REXULTI, CAPLYTA, COBENFY, VRAYLAR, ABILIFY MAINTENA, Auvelity, INGREZZA.
Industry payments across MI — which companies pay providers there.
